[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-174243-en":3,"doc-seo-174243-105":30,"detail-sidebar-cat-1-en-105":92},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":11,"category_id":12,"category_name":13,"doc_title":14,"doc_description":15,"doc_content":16,"file_id":17,"file_url":18,"file_type":19,"file_size":20,"view_count":11,"is_deleted":4,"is_public":11,"is_downloadable":11,"audit_status":11,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":27,"seo_description":15,"update_tm":28,"read_time":29},174243,1099523885074,"Riley West","https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc",1,18,"Letters","[AMENDED AND RESTATED] Voting Agreement","Amended and Restated Voting Agreement establishes voting and governance obligations among a Delaware corporation and designated stockholders, including Investors holding Series A (and optional Series B) Preferred Stock and Key Holders identified on schedules. The agreement details board-related voting provisions, conditions and restrictions affecting corporate control actions, and the consequences through defined remedies and enforcement mechanisms. It further covers “Bad Actor” matters, term and miscellaneous provisions, voting mechanics, transfer-related commitments, notices, and dispute-resolution procedures, supported by adoption and consent exhibits.","[AMENDED AND RESTATED]\nVOTING AGREEMENT\nTABLE OF CONTENTS\nNote to Drafter: Section headings have been formatted to automatically populate the Table of Contents. However, when editing this document for your own use, the page numbers may change. In order to reflect the correct page numbers in the Table of Contents, you must “update page numbers” to the Table of Contents by (1) right-clicking anywhere in the Table of Contents, and (2) choose “update field,” then “update page numbers only.” If you add or delete section headings, follow step (1) and (2) above and choose “update entire table.”\nPage\n\u0013TOC \\o \"1-2\" \\h \\z\u0014\u0013 HYPERLINK \\l \"_Toc469383984\" \u00141.\tVoting Provisions Regarding Board\t\u0013 PAGEREF _Toc469383984 \\h \u00142\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383985\" \u00141.1\tSize of the Board\t\u0013 PAGEREF _Toc469383985 \\h \u00142\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383986\" \u00141.2\tBoard Composition\t\u0013 PAGEREF _Toc469383986 \\h \u00142\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383987\" \u00141.3\tFailure to Designate a Board Member\t\u0013 PAGEREF _Toc469383987 \\h \u00144\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383988\" \u00141.4\tRemoval of Board Members\t\u0013 PAGEREF _Toc469383988 \\h \u00144\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383989\" \u00141.5\tNo Liability for Election of Recommended Directors\t\u0013 PAGEREF _Toc469383989 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383990\" \u00141.6\tNo “Bad Actor” Designees\t\u0013 PAGEREF _Toc469383990 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383991\" \u00142.\tVote to Increase Authorized Common Stock\t\u0013 PAGEREF _Toc469383991 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383992\" \u00143.\t[Drag-Along Right\t\u0013 PAGEREF _Toc469383992 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383993\" \u00143.1\tDefinitions\t\u0013 PAGEREF _Toc469383993 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383994\" \u00143.2\tActions to be Taken\t\u0013 PAGEREF _Toc469383994 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383995\" \u00143.3\tConditions\t\u0013 PAGEREF _Toc469383995 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383996\" \u00143.4\tRestrictions on Sales of Control of the Company\t\u0013 PAGEREF _Toc469383996 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383997\" \u00144.\tRemedies\t\u0013 PAGEREF _Toc469383997 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383998\" \u00144.1\tCovenants of the Company\t\u0013 PAGEREF _Toc469383998 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469383999\" \u00144.2\t[Irrevocable Proxy and Power of Attorney\t\u0013 PAGEREF _Toc469383999 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384000\" \u00144.3\tSpecific Enforcement\t\u0013 PAGEREF _Toc469384000 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384001\" \u00144.4\tRemedies Cumulative\t\u0013 PAGEREF _Toc469384001 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384002\" \u00145.\t“Bad Actor” Matters.\t\u0013 PAGEREF _Toc469384002 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384003\" \u00145.1\tDefinitions\t\u0013 PAGEREF _Toc469384003 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384004\" \u00145.2\tRepresentations\t\u0013 PAGEREF _Toc469384004 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384005\" \u00145.3\tCovenants\t\u0013 PAGEREF _Toc469384005 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384006\" \u00146.\tTerm\t\u0013 PAGEREF _Toc469384006 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384007\" \u00147.\tMiscellaneous\t\u0013 PAGEREF _Toc469384007 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384008\" \u00147.1\tAdditional Parties\t\u0013 PAGEREF _Toc469384008 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384009\" \u00147.2\tTransfers\t\u0013 PAGEREF _Toc469384009 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384010\" \u00147.3\tSuccessors and Assigns\t\u0013 PAGEREF _Toc469384010 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384011\" \u00147.4\tGoverning Law\t\u0013 PAGEREF _Toc469384011 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384012\" \u00147.5\tCounterparts\t\u0013 PAGEREF _Toc469384012 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384013\" \u00147.6\tTitles and Subtitles\t\u0013 PAGEREF _Toc469384013 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384014\" \u00147.7\tNotices\t\u0013 PAGEREF _Toc469384014 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384015\" \u00147.8\tConsent Required to Amend, Modify, Terminate or Waive\t\u0013 PAGEREF _Toc469384015 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384016\" \u00147.9\tDelays or Omissions\t\u0013 PAGEREF _Toc469384016 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384017\" \u00147.10\tSeverability\t\u0013 PAGEREF _Toc469384017 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384018\" \u00147.11\tEntire Agreement\t\u0013 PAGEREF _Toc469384018 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384019\" \u00147.12\tShare Certificate Legend\t\u0013 PAGEREF _Toc469384019 \\h \u001418\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc469384020\" \u00147.13\tStock Splits, Stock Dividends, etc.\t\u0013 PAGEREF _Toc469384020 \\h \u001418\u0015\u0015\n\u0013 HYPERLINK \\l \"_T","cbCaiiQR5x7bRM2d","https://ap.wps.com/l/cbCaiiQR5x7bRM2d","docx",111633,36,"English","en",105,"# Voting Provisions Regarding Board\n## Size of the Board\n## Board Composition\n## Failure to Designate a Board Member\n## Removal of Board Members\n## No Liability for Election of Recommended Directors\n## No “Bad Actor” Designees\n# Vote to Increase Authorized Common Stock\n# [Drag-Along Right\n## Definitions\n## Actions to be Taken\n## Conditions\n## Restrictions on Sales of Control of the Company\n# Remedies\n## Covenants of the Company\n## [Irrevocable Proxy and Power of Attorney\n## Specific Enforcement\n## Remedies Cumulative\n# “Bad Actor” Matters.\n## Definitions\n## Representations\n## Covenants\n# Term\n# Miscellaneous\n## Additional Parties\n## Transfers\n## Successors and Assigns\n## Governing Law\n## Counterparts\n## Titles and Subtitles\n## Notices\n## Consent Required to Amend, Modify, Terminate or Waive\n## Delays or Omissions\n## Severability\n## Entire Agreement\n## Share Certificate Legend\n## Stock Splits, Stock Dividends, etc.\n## Manner of Voting\n## Further Assurances\n## Dispute Resolution\n## [Costs of Enforcement\n## Aggregation of Stock\n## [Spousal Consent\n# Schedules and Exhibits","[{\"question\":\"谁需要签署该 Amended and Restated Voting Agreement？\",\"answer\":\"协议由公司、持有优先股的Investors以及依据Schedule B列明的Key Holders共同签署，并且后续满足条件并成为协议当事方的人也可加入。\"},{\"question\":\"协议对董事会相关的投票有哪些核心要求？\",\"answer\":\"协议包含董事会规模与组成、未能指定董事成员的处理、董事移除、以及对推荐董事选举不存在责任等安排，并进一步设定与“Bad Actor”相关的限制。\"},{\"question\":\"当出现不符合约定的情况，协议如何提供救济？\",\"answer\":\"协议通过“Remedies”章节规定可采取的救济措施，包括公司承诺、不可撤销的委托/授权、特定履行以及救济的累积性，同时配套争议解决与执行成本等条款。\"}]","[AMENDED AND RESTATED] Voting Agreement | DOCX",1788311407,13,{"code":4,"msg":31,"data":32},"ok",{"site_id":24,"language":23,"slug":33,"title":14,"keywords":34,"description":15,"schema_data":35,"social_meta":87,"head_meta":89,"extra_data":91,"updated_unix":28},"amended-and-restated-voting-agreement","",{"@graph":36,"@context":86},[37,54,69],{"@type":38,"itemListElement":39},"BreadcrumbList",[40,44,48,51],{"item":41,"name":42,"@type":43,"position":11},"https://docshare.wps.com","Home","ListItem",{"item":45,"name":46,"@type":43,"position":47},"https://docshare.wps.com/template/","Template",2,{"item":49,"name":13,"@type":43,"position":50},"https://docshare.wps.com/template/letters/",3,{"item":52,"name":14,"@type":43,"position":53},"https://docshare.wps.com/template/amended-and-restated-voting-agreement/174243/",4,{"url":52,"name":14,"@type":55,"author":56,"headline":14,"publisher":58,"fileFormat":61,"inLanguage":23,"description":15,"dateModified":62,"datePublished":63,"encodingFormat":61,"isAccessibleForFree":64,"interactionStatistic":65},"DigitalDocument",{"name":9,"@type":57},"Person",{"url":41,"name":59,"@type":60},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-09-05","2026-09-02",true,{"@type":66,"interactionType":67,"userInteractionCount":53},"InteractionCounter",{"@type":68},"ViewAction",{"@type":70,"mainEntity":71},"FAQPage",[72,78,82],{"name":73,"@type":74,"acceptedAnswer":75},"谁需要签署该 Amended and Restated Voting Agreement？","Question",{"text":76,"@type":77},"协议由公司、持有优先股的Investors以及依据Schedule B列明的Key Holders共同签署，并且后续满足条件并成为协议当事方的人也可加入。","Answer",{"name":79,"@type":74,"acceptedAnswer":80},"协议对董事会相关的投票有哪些核心要求？",{"text":81,"@type":77},"协议包含董事会规模与组成、未能指定董事成员的处理、董事移除、以及对推荐董事选举不存在责任等安排，并进一步设定与“Bad Actor”相关的限制。",{"name":83,"@type":74,"acceptedAnswer":84},"当出现不符合约定的情况，协议如何提供救济？",{"text":85,"@type":77},"协议通过“Remedies”章节规定可采取的救济措施，包括公司承诺、不可撤销的委托/授权、特定履行以及救济的累积性，同时配套争议解决与执行成本等条款。","https://schema.org",{"og:url":52,"og:type":88,"og:title":14,"og:site_name":59,"og:description":15},"article",{"robots":90,"canonical":52},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":93},[94,99,104,109,114,119,124,127,132],{"id":95,"doc_module":11,"doc_module_name":46,"category_name":96,"show_sort_weight":97,"slug":98},11,"Presentations",90,"presentations",{"id":100,"doc_module":11,"doc_module_name":46,"category_name":101,"show_sort_weight":102,"slug":103},12,"Resumes",80,"resumes",{"id":105,"doc_module":11,"doc_module_name":46,"category_name":106,"show_sort_weight":107,"slug":108},14,"Invoices",70,"invoices",{"id":110,"doc_module":11,"doc_module_name":46,"category_name":111,"show_sort_weight":112,"slug":113},15,"Posters",60,"posters",{"id":115,"doc_module":11,"doc_module_name":46,"category_name":116,"show_sort_weight":117,"slug":118},16,"Social Media",50,"social-media",{"id":120,"doc_module":11,"doc_module_name":46,"category_name":121,"show_sort_weight":122,"slug":123},17,"Forms",40,"forms",{"id":12,"doc_module":11,"doc_module_name":46,"category_name":13,"show_sort_weight":125,"slug":126},30,"letters",{"id":128,"doc_module":11,"doc_module_name":46,"category_name":129,"show_sort_weight":130,"slug":131},21,"Paper Templates",5,"papers-templates",{"id":133,"doc_module":11,"doc_module_name":46,"category_name":134,"show_sort_weight":4,"slug":135},158,"General","general-158"]